1 Introduction to Research & Analysis Reports
    1.1 Liquid Tumor Biopsy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Liquid Tumor Biopsy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Liquid Tumor Biopsy Overall Market Size
    2.1 Global Liquid Tumor Biopsy Market Size: 2021 VS 2027
    2.2 Global Liquid Tumor Biopsy Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Liquid Tumor Biopsy Players in Global Market
    3.2 Top Global Liquid Tumor Biopsy Companies Ranked by Revenue
    3.3 Global Liquid Tumor Biopsy Revenue by Companies
    3.4 Top 3 and Top 5 Liquid Tumor Biopsy Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Liquid Tumor Biopsy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Liquid Tumor Biopsy Players in Global Market
        3.6.1 List of Global Tier 1 Liquid Tumor Biopsy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Liquid Tumor Biopsy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Liquid Tumor Biopsy Market Size Markets, 2021 & 2027
        4.1.2 ctDNA
        4.1.3 CTC
    4.2 By Type - Global Liquid Tumor Biopsy Revenue & Forecasts
        4.2.1 By Type - Global Liquid Tumor Biopsy Revenue, 2016-2021
        4.2.2 By Type - Global Liquid Tumor Biopsy Revenue, 2022-2027
        4.2.3 By Type - Global Liquid Tumor Biopsy Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Liquid Tumor Biopsy Market Size, 2021 & 2027
        5.1.2 Clinical Laboratories
        5.1.3 Hospital
    5.2 By Application - Global Liquid Tumor Biopsy Revenue & Forecasts
        5.2.1 By Application - Global Liquid Tumor Biopsy Revenue, 2016-2021
        5.2.2 By Application - Global Liquid Tumor Biopsy Revenue, 2022-2027
        5.2.3 By Application - Global Liquid Tumor Biopsy Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Liquid Tumor Biopsy Market Size, 2021 & 2027
    6.2 By Region - Global Liquid Tumor Biopsy Revenue & Forecasts
        6.2.1 By Region - Global Liquid Tumor Biopsy Revenue, 2016-2021
        6.2.2 By Region - Global Liquid Tumor Biopsy Revenue, 2022-2027
        6.2.3 By Region - Global Liquid Tumor Biopsy Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Liquid Tumor Biopsy Revenue, 2016-2027
        6.3.2 US Liquid Tumor Biopsy Market Size, 2016-2027
        6.3.3 Canada Liquid Tumor Biopsy Market Size, 2016-2027
        6.3.4 Mexico Liquid Tumor Biopsy Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Liquid Tumor Biopsy Revenue, 2016-2027
        6.4.2 Germany Liquid Tumor Biopsy Market Size, 2016-2027
        6.4.3 France Liquid Tumor Biopsy Market Size, 2016-2027
        6.4.4 U.K. Liquid Tumor Biopsy Market Size, 2016-2027
        6.4.5 Italy Liquid Tumor Biopsy Market Size, 2016-2027
        6.4.6 Russia Liquid Tumor Biopsy Market Size, 2016-2027
        6.4.7 Nordic Countries Liquid Tumor Biopsy Market Size, 2016-2027
        6.4.8 Benelux Liquid Tumor Biopsy Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Liquid Tumor Biopsy Revenue, 2016-2027
        6.5.2 China Liquid Tumor Biopsy Market Size, 2016-2027
        6.5.3 Japan Liquid Tumor Biopsy Market Size, 2016-2027
        6.5.4 South Korea Liquid Tumor Biopsy Market Size, 2016-2027
        6.5.5 Southeast Asia Liquid Tumor Biopsy Market Size, 2016-2027
        6.5.6 India Liquid Tumor Biopsy Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Liquid Tumor Biopsy Revenue, 2016-2027
        6.6.2 Brazil Liquid Tumor Biopsy Market Size, 2016-2027
        6.6.3 Argentina Liquid Tumor Biopsy Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Liquid Tumor Biopsy Revenue, 2016-2027
        6.7.2 Turkey Liquid Tumor Biopsy Market Size, 2016-2027
        6.7.3 Israel Liquid Tumor Biopsy Market Size, 2016-2027
        6.7.4 Saudi Arabia Liquid Tumor Biopsy Market Size, 2016-2027
        6.7.5 UAE Liquid Tumor Biopsy Market Size, 2016-2027
7 Players Profiles
    7.1 Abbott Laboratories
        7.1.1 Abbott Laboratories Corporate Summary
        7.1.2 Abbott Laboratories Business Overview
        7.1.3 Abbott Laboratories Liquid Tumor Biopsy Major Product Offerings
        7.1.4 Abbott Laboratories Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.1.5 Abbott Laboratories Key News
    7.2 Bio-Rad Laboratories
        7.2.1 Bio-Rad Laboratories Corporate Summary
        7.2.2 Bio-Rad Laboratories Business Overview
        7.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Major Product Offerings
        7.2.4 Bio-Rad Laboratories Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.2.5 Bio-Rad Laboratories Key News
    7.3 F. Hoffmann-La Roche
        7.3.1 F. Hoffmann-La Roche Corporate Summary
        7.3.2 F. Hoffmann-La Roche Business Overview
        7.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Major Product Offerings
        7.3.4 F. Hoffmann-La Roche Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.3.5 F. Hoffmann-La Roche Key News
    7.4 Illumina
        7.4.1 Illumina Corporate Summary
        7.4.2 Illumina Business Overview
        7.4.3 Illumina Liquid Tumor Biopsy Major Product Offerings
        7.4.4 Illumina Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.4.5 Illumina Key News
    7.5 QIAGEN N.V.
        7.5.1 QIAGEN N.V. Corporate Summary
        7.5.2 QIAGEN N.V. Business Overview
        7.5.3 QIAGEN N.V. Liquid Tumor Biopsy Major Product Offerings
        7.5.4 QIAGEN N.V. Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.5.5 QIAGEN N.V. Key News
    7.6 Thermo Fisher Scientific
        7.6.1 Thermo Fisher Scientific Corporate Summary
        7.6.2 Thermo Fisher Scientific Business Overview
        7.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Major Product Offerings
        7.6.4 Thermo Fisher Scientific Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.6.5 Thermo Fisher Scientific Key News
    7.7 Amoy Diagnostics
        7.7.1 Amoy Diagnostics Corporate Summary
        7.7.2 Amoy Diagnostics Business Overview
        7.7.3 Amoy Diagnostics Liquid Tumor Biopsy Major Product Offerings
        7.4.4 Amoy Diagnostics Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.7.5 Amoy Diagnostics Key News
    7.8 HaploX
        7.8.1 HaploX Corporate Summary
        7.8.2 HaploX Business Overview
        7.8.3 HaploX Liquid Tumor Biopsy Major Product Offerings
        7.8.4 HaploX Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.8.5 HaploX Key News
    7.9 Whole Genome Sequencing
        7.9.1 Whole Genome Sequencing Corporate Summary
        7.9.2 Whole Genome Sequencing Business Overview
        7.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Major Product Offerings
        7.9.4 Whole Genome Sequencing Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.9.5 Whole Genome Sequencing Key News
    7.10 Burning Rock Biotech
        7.10.1 Burning Rock Biotech Corporate Summary
        7.10.2 Burning Rock Biotech Business Overview
        7.10.3 Burning Rock Biotech Liquid Tumor Biopsy Major Product Offerings
        7.10.4 Burning Rock Biotech Liquid Tumor Biopsy Revenue in Global (2016-2021)
        7.10.5 Burning Rock Biotech Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer